HARARE – Zimbabwe Stock Exchange (ZSE)-listed pharmaceuticals manufacturer Medtech is facing an uncertain future should a strategic transaction fail to go through...
To access this post, you must purchase a subscription. Please click the button below to visit our subscriptions page to select a package.
Subscriptions 
